Picture of Ecolab logo

ECL — Ecolab News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsConservativeLarge CapHigh Flyer

Ecolab's Q1 adjusted EPS up 13%, sales beat estimates

Overview

US water, hygiene and infection prevention provider's Q1 sales rose 10%, beating analyst expectations

Adjusted diluted EPS for Q1 grew 13% and met analyst expectations

Company repurchased 1.3 mln shares during Q1

Outlook

Ecolab maintains 2026 adjusted diluted EPS outlook at $8.43-$8.63, up 12%-15%

Company expects Q2 2026 adjusted diluted EPS of $2.02-$2.12, up 7%-12%

Result Drivers

VALUE PRICING - Co said strong value pricing contributed to double-digit EPS growth

SEGMENT GROWTH - Accelerated growth in Life Sciences, Global High-Tech, Institutional and Specialty led organic sales gains

PRODUCTIVITY IMPROVEMENTS - Co said improved productivity helped offset higher commodity costs

Company press release: ID:nBw4JHxRra

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 SalesBeat$4.07 bln$4.02 bln (17 Analysts)
Q1 Adjusted EPSMeet$1.70$1.70 (21 Analysts)
Q1 EPS$1.52
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy", 9 "hold" and no "sell" or "strong sell" The average consensus recommendation for the specialty chemicals peer group is "buy" Wall Street's median 12-month price target for Ecolab Inc is $327.50, about 22.3% above its April 27 closing price of $267.88 The stock recently traded at 30 times the next 12-month earnings vs. a P/E of 31 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Ecolab

See all news